|
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Nov. 17, 2015) - BioHEP Technologies Ltd. (the "Company") is pleased to announce that it will enter into a convertible loan agreement (the "Loan Agreement") with 7 parties, including two directors and one officer, (collectively, the "Lenders") whereby the Lenders have agreed to lend the Company an aggregate sum of $130,000, primarily to pay current liabilities, provide working capital and to further the Company's business plan. The loan is convertible at a deemed price of $0.025 per share. |
